Avectas
Avectas develops non-viral cell engineering technology for scalable and affordable cell therapy manufacturing. Its Solupore Integrated platform consolidates multiple unit processes, including activation, transduction, expansion, and harvest, into a single closed, automated, sensor-enabled consumable. This approach reduces facility costs by up to 75%, increases throughput by 600%, and lowers cost of goods by up to…
Funding snapshot
About
Avectas develops non-viral cell engineering technology for scalable and affordable cell therapy manufacturing. Its Solupore Integrated platform consolidates multiple unit processes, including activation, transduction, expansion, and harvest, into a single closed, automated, sensor-enabled consumable. This approach reduces facility costs by up to 75%, increases throughput by 600%, and lowers cost of goods by up to 25% compared to conventional manufacturing workflows. The platform supports non-viral editing techniques including mRNA, CRISPR, and HDR workflows, producing potent CAR-T cells with stem-like phenotypes and low exhaustion markers. Solupore Integrated features GMP consumables with a Drug Master File filed with the FDA, 21 CFR Part 11 electronic batch records, and a US-established supply chain. Founded in 2011 and headquartered in Dublin, Ireland, the company has raised approximately $33.5 million at the Series C stage, and has partnered with CCRM and OmniaBio to improve cell therapy manufacturing.
Business model
Genomics > Enabling Technologies > Technology Platforms > Genetic Engineering,
Life Sciences Platforms and Tools > Research Services > Diversified
Founders & team highlights
Serial Founder
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.